This new review explores a wide array of new therapeutic options for the treatment of systemic sclerosis, including biologic and immunosuppressive therapies, among others. Nature Reviews Rheumatology
Disease-modifying anti-rheumatic drugs are as effective as the biologic agent etanercept plus methotrexate for the treatment of early aggressive rheumatoid arthritis. Medscape Medical News
Renal complications are important in scleroderma (systemic sclerosis) and include scleroderma renal crisis. Key aspects of management and outcome are reviewed. Current Opinion in Rheumatology
